التفاصيل البيبلوغرافية
العنوان: |
Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial |
المؤلفون: |
Hobbs, F. D. Richard, Montgomery, Hugh, Padilla, Francisco, Simón-Campos, Jesus Abraham, Kim, Kenneth, Arbetter, Douglas, Padilla, Kelly W., Reddy, Venkatesh Pilla, Seegobin, Seth, Streicher, Katie, Templeton, Alison, Viani, Rolando M., Johnsson, Eva, Koh, Gavin C. K. W., Esser, Mark T. |
المساهمون: |
AstaZeneca |
المصدر: |
Infectious Diseases and Therapy ; volume 12, issue 9, page 2269-2287 ; ISSN 2193-8229 2193-6382 |
بيانات النشر: |
Springer Science and Business Media LLC |
سنة النشر: |
2023 |
مصطلحات موضوعية: |
Infectious Diseases, Microbiology (medical) |
نوع الوثيقة: |
article in journal/newspaper |
اللغة: |
English |
DOI: |
10.1007/s40121-023-00861-7 |
DOI: |
10.1007/s40121-023-00861-7.pdf |
DOI: |
10.1007/s40121-023-00861-7/fulltext.html |
الإتاحة: |
https://doi.org/10.1007/s40121-023-00861-7Test |
حقوق: |
https://creativecommons.org/licenses/by-nc/4.0Test ; https://creativecommons.org/licenses/by-nc/4.0Test |
رقم الانضمام: |
edsbas.27160446 |
قاعدة البيانات: |
BASE |